KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $885.7 million.

  • Edwards Lifesciences' Operating Expenses rose 2515.19% to $885.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year increase of 1444.04%. This contributed to the annual value of $2.9 billion for FY2024, which is 561.32% up from last year.
  • Edwards Lifesciences' Operating Expenses amounted to $885.7 million in Q3 2025, which was up 2515.19% from $793.7 million recorded in Q2 2025.
  • Edwards Lifesciences' 5-year Operating Expenses high stood at $885.7 million for Q3 2025, and its period low was $381.5 million during Q4 2022.
  • Over the past 5 years, Edwards Lifesciences' median Operating Expenses value was $668.6 million (recorded in 2023), while the average stood at $675.9 million.
  • As far as peak fluctuations go, Edwards Lifesciences' Operating Expenses crashed by 4253.65% in 2022, and later surged by 7525.56% in 2023.
  • Edwards Lifesciences' Operating Expenses (Quarter) stood at $663.9 million in 2021, then plummeted by 42.54% to $381.5 million in 2022, then skyrocketed by 75.26% to $668.6 million in 2023, then increased by 18.32% to $791.1 million in 2024, then rose by 11.96% to $885.7 million in 2025.
  • Its Operating Expenses was $885.7 million in Q3 2025, compared to $793.7 million in Q2 2025 and $731.2 million in Q1 2025.